SPC
Slate Path Capital’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139M | Sell |
8,289,998
-1,366,000
| -14% | -$22.9M | 2.4% | 17 |
|
|
2025
Q1 | $148M | Buy |
9,655,998
+1,164,965
| +14% | +$17.9M | 2.68% | 14 |
|
|
2024
Q4 | $187M | Sell |
8,491,033
-5,177,200
| -38% | -$114M | 3.38% | 9 |
|
|
2024
Q3 | $246M | Sell |
13,668,233
-6,522,951
| -32% | -$118M | 3.79% | 5 |
|
|
2024
Q2 | $328M | Sell |
20,191,184
-6,705,000
| -25% | -$109M | 6.25% | 1 |
|
|
2024
Q1 | $380M | Buy |
26,896,184
+665,000
| +3% | +$9.38M | 7.52% | 1 |
|
|
2023
Q4 | $274M | Buy |
26,231,184
+2,387,184
| +10% | +$24.9M | 6.08% | 2 |
|
|
2023
Q3 | $243M | Buy |
23,844,000
+11,407,000
| +92% | +$116M | 6.78% | 2 |
|
|
2023
Q2 | $93.7M | Buy |
+12,437,000
| New | +$93.7M | 3.42% | 12 |
|